Industries > Pharma > Drug Delivery Technologies Market Forecast 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines

PUBLISHED: 27 February 2019
PAGES: 180
PRODUCT CODE: PHA0356

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures – all unavailable elsewhere.

The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Drug Delivery Technologies market forecasts from 2019-2029

• Drug Delivery Technologies submarket forecasts from 2019-2029 covering:
• Oral Drug Delivery Technology
• Inhalable Drug Delivery Technology
• Injectable/Implantable Drug Delivery Technology
• Transdermal Drug Delivery Technology
• Ocular Drug Delivery Technology
• Nasal/Buccal Drug Delivery Technology

This report discusses the drivers and restraints of each submarket.

• Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering:
• North America: US, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
• Latin America: Brazil and Rest of Latin America
• Rest of the World: Middle East, Africa

Drug Delivery Technologies Market Forecast 2019-2029

• Assessment of the leading companies in the Drug Delivery Technologies market:
• 3M
• Alkermes PLC
• Altea Therapeutics Corporation
• Antares Pharma Inc.
• Applied Pharma Research S.A. (APR)
• Becton, Dickinson & Company
• Ethypharm SA
• Glycologic Limited
• Intercell AG
• NanoPass Technologies Ltd.
• pSivida

SWOT analysis of the drug delivery technologies market

Visiongain’s study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.

Buy our report today Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category